# An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml

> **NCT00002172** · NA · COMPLETED · sponsor: **The Immune Response Corporation**

## Conditions studied

- HIV Infections

## Interventions

- **BIOLOGICAL:** HIV-1 Immunogen

## Key facts

- **NCT ID:** NCT00002172
- **Lead sponsor:** The Immune Response Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2005-06-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00002172

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00002172, "An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00002172. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*